Click on the indication in which you are interested. SUTENT has been approved to
treat 2 types of cancer:
Advanced kidney cancer. This is also called advanced
renal cell carcinoma (RCC)
A cancer of the digestive (gastrointestinal) system called
gastrointestinal stromal tumor (GIST). SUTENT is used when the medicine Gleevec®
(imatinib mesylate) does not stop the cancer from growing. It may also be used when
you cannot take Gleevec
Click below to confirm that you are a health care professional, and go to the SUTENT
HCP Web site: